These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

432 related items for PubMed ID: 31853871

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Use of voriconazole to successfully treat disseminated Trichosporon asahii infection in a patient with acute myeloid leukaemia.
    Fournier S, Pavageau W, Feuillhade M, Deplus S, Zagdanski AM, Verola O, Dombret H, Molina JM.
    Eur J Clin Microbiol Infect Dis; 2002 Dec; 21(12):892-6. PubMed ID: 12525928
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Epidemiology and Antifungal Susceptibility of Infections Caused by Trichosporon Species: An Emerging Non-Candida and Non-Cryptococcus Yeast Worldwide.
    Singh S, Capoor MR, Varshney S, Gupta DK, Verma PK, Ramesh V.
    Indian J Med Microbiol; 2019 Dec; 37(4):536-541. PubMed ID: 32436877
    [Abstract] [Full Text] [Related]

  • 25. Emerging pan-resistance in Trichosporon species: a case report.
    Oliveira dos Santos C, Zijlstra JG, Porte RJ, Kampinga GA, van Diepeningen AD, Sinha B, Bathoorn E.
    BMC Infect Dis; 2016 Apr 14; 16():148. PubMed ID: 27074951
    [Abstract] [Full Text] [Related]

  • 26. Pseudozyma and other non-Candida opportunistic yeast bloodstream infections in a large stem cell transplant center.
    Pande A, Non LR, Romee R, Santos CA.
    Transpl Infect Dis; 2017 Apr 14; 19(2):. PubMed ID: 28099778
    [Abstract] [Full Text] [Related]

  • 27. Endogenous Trichosporon Asahii Retinitis.
    Parrozzani R, Marchione G, Midena G.
    Ophthalmology; 2022 Jan 14; 129(1):66. PubMed ID: 34930551
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Successful Outcome of Disseminated Fusarium musae Fungemia with Skin Localization Treated with Liposomal Amphotericin B and Voriconazole in a Patient with Acute Myeloid Leukemia.
    Verbeke V, Bourgeois T, Lodewyck T, Van Praet J, Lagrou K, Reynders M, Nulens E.
    Mycopathologia; 2020 Dec 14; 185(6):1085-1089. PubMed ID: 33119817
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. A case report of catheter-related bloodstream infection due to Trichosporon coremiiforme in a patient with secondary neutropenia to HIV.
    Monzani V, Córdoba S, Vivot M, Arias B, Vivot W, Szusz W, Castellaro P, Appendino A, Taverna CG.
    J Mycol Med; 2020 Apr 14; 30(1):100916. PubMed ID: 31843296
    [Abstract] [Full Text] [Related]

  • 36. Breakthrough Candida dubliniensis fungemia in an acute myeloid leukemia patient during voriconazole therapy successfully treated with caspofungin.
    Fanci R.
    J Chemother; 2009 Feb 14; 21(1):105-7. PubMed ID: 19297283
    [No Abstract] [Full Text] [Related]

  • 37. Comparison of the characteristics of patients with invasive infections and noninvasive infections caused by Trichosporon asahii.
    Kim J, Kim MJ, Chong YP, Kim SH, Choi SH, Lee SO, Woo JH, Kim YS, Jung J.
    Med Mycol; 2021 Mar 04; 59(3):296-300. PubMed ID: 32876327
    [Abstract] [Full Text] [Related]

  • 38. In vitro combined activity of amphotericin B, caspofungin and voriconazole against clinical isolates of Trichosporon asahii.
    Li H, Lu Q, Wan Z, Zhang J.
    Int J Antimicrob Agents; 2010 Jun 04; 35(6):550-2. PubMed ID: 20202797
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.